- Home
- EDAP vs THTX Comparison
EDAP vs THTX Comparison
Compare EDAP & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDAP
- THTX
- Stock Information
- Founded
- EDAP 1979
- THTX 1993
- Country
- EDAP France
- THTX Canada
- Employees
- EDAP N/A
- THTX N/A
- Industry
- EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
- THTX Biotechnology: Pharmaceutical Preparations
- Sector
- EDAP Health Care
- THTX Health Care
- Exchange
- EDAP Nasdaq
- THTX Nasdaq
- Market Cap
- EDAP 81.6M
- THTX 93.3M
- IPO Year
- EDAP 1997
- THTX N/A
- Fundamental
- Price
- EDAP $2.17
- THTX $1.72
- Analyst Decision
- EDAP Strong Buy
- THTX Hold
- Analyst Count
- EDAP 1
- THTX 1
- Target Price
- EDAP $19.00
- THTX N/A
- AVG Volume (30 Days)
- EDAP 70.3K
- THTX 178.5K
- Earning Date
- EDAP 11-07-2024
- THTX 02-19-2025
- Dividend Yield
- EDAP N/A
- THTX N/A
- EPS Growth
- EDAP N/A
- THTX N/A
- EPS
- EDAP N/A
- THTX N/A
- Revenue
- EDAP $70,722,730.00
- THTX $84,316,000.00
- Revenue This Year
- EDAP $6.96
- THTX $5.78
- Revenue Next Year
- EDAP $15.53
- THTX $2.47
- P/E Ratio
- EDAP N/A
- THTX N/A
- Revenue Growth
- EDAP 12.17
- THTX 5.75
- 52 Week Low
- EDAP $2.00
- THTX $1.08
- 52 Week High
- EDAP $8.50
- THTX $2.18
- Technical
- Relative Strength Index (RSI)
- EDAP 45.70
- THTX 50.28
- Support Level
- EDAP $2.12
- THTX $1.69
- Resistance Level
- EDAP $2.26
- THTX $1.83
- Average True Range (ATR)
- EDAP 0.16
- THTX 0.13
- MACD
- EDAP -0.01
- THTX -0.04
- Stochastic Oscillator
- EDAP 27.42
- THTX 19.30
About EDAP EDAP TMS S.A.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its global activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.